• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.33 Down 0.01(0.23%) Mar 27, 4:00PM EDT
    |After Hours : 4.32 Down 0.01 (0.23%) Mar 27, 4:53PM EDT
    Add to Portfolio
    Prev Close:4.34
    Open:4.32
    Bid:4.01 x 1000
    Ask:4.46 x 3000
    1y Target Est:7.58
    Beta:-4.12
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:4.28 - 4.44
    52wk Range:3.26 - 7.22
    Volume:2,684,092
    Avg Vol (3m):8,989,480
    Market Cap:1.05B
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 0.23%1.05B
    GSKUp 0.77%113.11B
    OREXUp 4.00%932.90M
    RHHBYDown 0.23%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):28.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.53
    Quarterly EPS Est (Mar-15) :-0.14
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback